MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3).

O M Sobulo; J Borrow; R Tomek; S Reshmi; A Harden; B Schlegelberger; D Housman; N A Doggett; J D Rowley; N J Zeleznik-Le

doi:10.1073/pnas.94.16.8732

MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3).

Identifier:nobleid.org/w1/20260515/17BBC2DA

Type:Conference Paper

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/17BBC2DA.svg?ark=w1%2F20260515%2F17BBC2DA)](https://nobleid.org/work/w1/20260515/17BBC2DA)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3).

Identifier:nobleid.org/w1/20260515/17BBC2DA

Type:Conference Paper

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/17BBC2DA.svg?ark=w1%2F20260515%2F17BBC2DA)](https://nobleid.org/work/w1/20260515/17BBC2DA)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work